The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $42.41

Today's change-0.28 -0.66%
Updated March 28 4:02 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $42.41

Today's change-0.28 -0.66%
Updated March 28 4:02 PM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC down (U.S.)$0.28

GlaxoSmithKline PLC closed lower Tuesday, dropping (U.S.)$0.28 or 0.66% to (U.S.)$42.41. Over the last five days, shares are unchanged, but have gained 10.13% over the last year to date. This security has underperformed the S&P 500 by 8.55% during the last year.

Key company metrics

  • Open(U.S.) $42.61
  • Previous close(U.S.) $42.69
  • High(U.S.) $42.67
  • Low(U.S.) $42.37
  • Bid / Ask(U.S.) $42.32 / (U.S.) $42.44
  • YTD % change+10.13%
  • Volume1,835,024
  • Average volume (10-day)2,489,350
  • Average volume (1-month)3,146,029
  • Average volume (3-month)3,584,798
  • 52-week range(U.S.) $37.20 to (U.S.) $45.58
  • Beta0.95
  • Trailing P/E91.27×
  • P/E 1 year forward15.41×
  • Forward PEG1.12×
  • Indicated annual dividend(U.S.) $2.01
  • Dividend yield4.73%
  • Trailing EPS(U.S.) $0.46
Updated March 28 4:02 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue7,5867,5426,5326,229
Total other revenue--------
Total revenue7,5867,5426,5326,229
Gross profit5,2575,0994,4764,159
Total cost of revenue2,3292,4432,0562,070
Total operating expense6,9916,1116,6835,506
Selling / general / administrative2,4762,2322,0752,076
Research & development1,017876800775
Depreciation / amortization10111010
Interest expense (income), net operating--------
Unusual expense (income)1,2766561,825666
Other operating expenses, total-117-107-83-91
Operating income5951,431-151723
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4231,274-318560
Income after tax317885-492352
Income tax, total106389174208
Net income257808-435282
Total adjustments to net income--------
Net income before extra. items257808-435282
Minority interest-60-7757-70
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items257808-435282
Inc. avail. to common incl. extra. items257808-435282
Diluted net income257809-435282
Dilution adjustment01--0
Diluted weighted average shares4,9574,9024,8594,890
Diluted EPS excluding extraordinary itemsvalue per share0.050.17-0.090.06
Dividends per sharevalue per share0.230.190.190.19
Diluted normalized EPSvalue per share0.250.300.260.18